Maturitas
Volume 61, Issue 1 , Pages 17-26, September 2008

“Reprint of” Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality☆☆

  • Susan R. Davis

      Affiliations

    • Corresponding Author InformationCorresponding author.
    • Prince Henry’s Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia
  • ,
  • Philip McCloud

      Affiliations

    • Monash University, Clayton, Victoria 3168, Australia
  • ,
  • Boyd J.G. Strauss

      Affiliations

    • Body Composition Laboratory, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
  • ,
  • Henry Burger

      Affiliations

    • Prince Henry’s Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia

Abstract 

To investigate the role of androgens in increasing bone density and improving low libido in postmenopausal women, we have studied the long-term effects of estradiol and testosterone implants on bone mineral density and sexuality in a prospective, 2 year, single-blind randomised trial. Thirty-four postmenopausal volunteers were randomised to treatment with either estradiol implants 50mg alone (E) or estradiol 50mg plus testosterone 50mg (E&T), administered 3-monthly for 2 years. Cyclical oral progestins were taken by those women with an intact uterus. Thirty-two women completed the study. BMD (DEXA) of total body, lumbar vertebrae (L1–L4) and hip area increased significantly in both treatment groups. BMD increased more rapidly in the testosterone treated group at all sites. A substantially greater increase in BMD occurred in the E&T group for total body (P<0.008), vertebral L1–L4 (P<0.001) and trochanteric (P<0.005) measurements. All sexual parameters (Sabbatsberg sexual self-rating scale) improved significantly in both groups. Addition of testosterone resulted in a significantly greater improvement compared to E for sexual activity (P<0.03), satisfaction (P<0.03), pleasure (P<0.01), orgasm (P<0.035) and relevancy (P<0.05). Total cholesterol and LDL-cholesterol fell in both groups as did total body fat. Total body fat-free mass (DEXA, anthropometry, impedance) increased in the E&T group only. We concluded that in postmenopausal women, treatment with combined estradiol and testosterone implants was more effective in increasing bone mineral density in the hip and lumbar spine than estradiol implants alone. Significantly greater improvement in sexuality was observed with combined therapy, verifying the therapeutic value of testosterone implants for diminished libido in postmenopausal women. The favourable estrogenic effects on lipids were preserved in women treated with T, in association with beneficial changes in body composition.

Keywords: Testosterone, Sexuality, Menopause, Bone density

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprint of an article originally published in Maturitas, 21(3), pp. 227–236.

☆☆ Presented at the 7th International Congress on the Menopause; Stockholm, Sweden, June 20–24, 1993 — Abstract Nos. 49 & 432.

PII: S0378-5122(08)00223-5

doi:10.1016/j.maturitas.2008.09.006

Maturitas
Volume 61, Issue 1 , Pages 17-26, September 2008